// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Sampled Population Study

P. Camp - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

World Canadian Cohort of Patients with Idiopathic Pulmonary Fibrosis Treated with Pirfenidone

C. Ryerson - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

Pirfenidone

Dyspnea Management in Interstitial Lung Disease: An Early Integrated Palliative Care Approach in a Multidisciplinary Setting

L. van den Bosch - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Interstitial lung disease

N/A

Predictors of Increased Length of ICU Stay Following Bilateral Lung Transplantation

A. Chruscicki - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Prevalence and Functional Impact of Diaphragm Involvement in Inclusion Body Myositis

M. Lelievre - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Inclusion body myositis

N/A

Respiratory Muscles Contraction After Successful Ventilator Liberation Trial Predicts Extubation Failure

M. Dres - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Acute respiratory failure

N/A

Mechanical Efficiency in Mechanically Ventilated Children

G. Emeriaud - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Centered Study

F. Salerno - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Dyspnea

Nitric oxide

Effect of Increasing Gas Flow and Resulting Increase in Peak Expiratory Pressure (PEP) from a New Positive Airway Pressure (PAP) Device

D. P. Coppolo - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Involvement of Patients and Professionals in the Development of a Conceptual Framework on Functional Health Literacy to Improve Chronic Airways Disease Outcomes

I. Poureslami - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis Mechanism Comparison on the Basis of Gene Expression Profiles

F. Xu - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Term Oral Prednisone Therapy on Blood Gene Expression

H. Takiguchi - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Prednisone

Inflammation Amplifies the Phenomenon of Force Adaptation in a Mouse Model of Allergic Asthma

M. Gazzola - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

SK1211

Preliminary Results from the DiSARM Trial

F. S. S. Leitao Filho - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Formoterol

Comparison of MRC Breathlessness Scale to a Novel Multidimensional Dyspnea Scale (MDDS) for Clinical Use

M. Kalluri - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Dyspnea

N/A

Macrophage Recruitment Mediators in the Lung of Chronic Heart Failure Patients

S. Puukila - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

24-hour Activity Profiling in People Living with Arthritis: Habits Matter

Linda Li - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Lupus

N/A

A Flexion Contracture Is a Risk Factor for Radiographic Progression and Earlier Need for Arthroplasty in Knee Osteoarthritis: Data from the Osteoarthritis Initiative

Dennis McGonagle - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

A Meta-Analysis of Anti-Ribosomal P Autoantibodies in Systemic Lupus Erythematosus: A Misunderstood Autoantibody

Rachael Brown - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

A Phase II Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Obinutuzumab or Placebo in Combination with Mycophenolate Mofetil in Patients with Active Class III or IV Lupus Nephritis

Gustavo Aroca - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Lupus nephritis

Mycophenolate mofetil

Copyright © 2026. QuantiNova All rights reserved